Patents by Inventor Seth Brunner

Seth Brunner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210268122
    Abstract: Two disparate biological mechanisms which predispose to the dissemination and metastases of solid tumors is described.
    Type: Application
    Filed: March 2, 2021
    Publication date: September 2, 2021
    Applicant: DYVE BIOSCIENCES, INC.
    Inventors: Ryan Beal, Bruce Sand, Seth Brunner, Brandon Sand, Kilmar Martinez, Luke Gonzales, Lisa Misell, Nathan Fitzsimmons
  • Publication number: 20190134219
    Abstract: Two disparate biological mechanisms which predispose to the dissemination and metastases of solid tumors is described.
    Type: Application
    Filed: September 15, 2018
    Publication date: May 9, 2019
    Applicant: AMPERSAND BIOPHARMACEUTICALS, INC.
    Inventors: Ryan Beal, Bruce Sand, Seth Brunner, Brandon Sand, Kilmar Martinez, Luke Gonzales, Lisa Misell, Nathan Fitzsimmons
  • Publication number: 20190083386
    Abstract: A formulation for transdermal delivery of one or more buffering agents through the skin of a subject, comprising: a buffering agent comprising at least one carbonate salt, lysine, tris, a phosphate buffer and/or 2-imidazole-1-yl-3-ethoxycarbonylpropionic acid (IEPA), or a combination thereof in an amount between about 10-56% w/w; and a penetrant portion in an amount between about 44 to 90% w/w, wherein the penetrant portion comprises water in an amount less than about 85% w/w, and wherein the formulation comprises less than about 12% w/w lecithin.
    Type: Application
    Filed: September 14, 2018
    Publication date: March 21, 2019
    Applicant: AMPERSAND BIOPHARMACEUTICALS, INC.
    Inventors: Seth Brunner, Ryan Beal, Bruce Sand, Brandon Sand, Kilmar Martinez, Luke Gonzales
  • Publication number: 20190083527
    Abstract: Provided herein are formulations for topical and/or transdermal administration, and methods of using these formulations for the treatment of proliferative diseases related to cancer such as cancers and related conditions, and solid minors. Also provided are formulations for topical and/or transdermal administration, and methods of using these formulations for melasma, gout, skin disorders, and other diseases and disorders described herein as well as methods for modulating the pH (e.g. raising) of a tissue or microenvironment proximal to a tumor, modulating pH, or improving the effectiveness of know chemotherapeutic agents, immunotherapy and the like for the prevention, treatment of cancers and related conditions described herein.
    Type: Application
    Filed: September 14, 2018
    Publication date: March 21, 2019
    Applicant: AMPERSAND BIOPHARMACEUTICALS, INC.
    Inventors: Ryan Beal, Seth Brunner, Bruce Sand, Jeff Byers, Lisa Misell, Nathan Fitzsimmons, Brandon Sand, Kilmar Martinez, Luke Gonzales
  • Publication number: 20070235331
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Application
    Filed: May 18, 2007
    Publication date: October 11, 2007
    Applicant: DexCom, Inc.
    Inventors: Peter Simpson, Robert Boock, James Petisce, Mark Brister, Monica Rixman, Kum Ming Woo, Lisa Nguyen, Seth Brunner, Arthur Chee, Melissa Nicholas, Matthew Wightlin, Jack Pryor, Dubravka Markovic